Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05179083
Other study ID # APP-21-04349
Secondary ID
Status Recruiting
Phase Phase 1
First received
Last updated
Start date August 20, 2022
Est. completion date August 31, 2024

Study information

Verified date December 2023
Source University of Southern California
Contact Jonathan J Russin, MD
Phone 800-872-2273
Email Jonathan.Russin@med.usc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nearly 100 million Americans are affected by neurological disorders with an overall cost above $765 billion for the more prevalent conditions. Given this significant burden, effective treatments to prevent dementia and new disease modifying therapies are urgently needed. Regeneration of lost neurons with new ones (i.e., neurogenesis) is compromised at early stages of dementia and in part correlates with cognitive impairment in Alzheimer's disease. Boosting the neurogenesis delays the cognitive impairment in animal models of dementia and has been proven beneficial in improving the memory in rodent studies. Aerobic exercise is the most potent known stimulator of neurogenesis in animal models. A crucial next step is to translate endogenous regenerative strategies to people. The purpose of this study is to demonstrate the feasibility and investigate the effects of an exercise program on neurogenesis and cognitive improvement in epilepsy patients.


Description:

Neurogenesis studies in healthy and dementia patients have only been performed on postmortem tissue, which prevents investigation of treatment outcomes. Patients with mesial temporal lobe epilepsy (MTLE) typically do not respond to medications and uniquely among related dementia disorders undergo corrective surgical treatment, providing a unique opportunity to study the value of regenerative interventions on hippocampal electrophysiology and neurogenesis. Using this unique approach, this study will investigate the neurogenesis and cognitive improvement in epilepsy patients. Ten people with MTLE who are recommended for surgical treatment as part of their standard care will be enrolled and randomly assigned to High Impact (n=5) and Low Impact (n=5) exercise groups. The duration of exercise programs will be 12 weeks and study arms will undergo the same protocol except for the target heart rate which will be higher in the High-Impact group. Exercise will be performed at home using a recliner bike under the supervision of caregiver and study personnel. Participants will undergo cognitive, exercise and clinical assessment at baseline and after completing the three-month exercise therapy; then surgically resected tissue will be analyzed for regeneration and epileptiform activity. The investigators will assess whether exercise would yield clinical benefits in terms of seizure frequency/intensity or cognitive ability, and whether the ability of the adult human brain to self-repair can be enhanced. It is hypothesized that the proposed exercise regimen is feasible and will improve the neurogenesis levels and cognition.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date August 31, 2024
Est. primary completion date August 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Age of 18 years or older - Medically resistant mesial temporal lobe epilepsy - Candidacy for standard or selective temporal lobectomy Exclusion Criteria: - Age of older than 65 years - Pregnancy - Physical disabilities or medical conditions preventing from participation in exercise program - Inability to receive exercise equipment at home - Cognitive/developmental disabilities restricting the participation in exercise program

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High-Impact Aerobic Exercise
Participants will be submitted to a 12-week high-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (80% of maximum) is reached, followed by 10 minutes of cool down.
Low-Impact Aerobic Exercise
Participants will be submitted to a 12-week low-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (40% of maximum) is reached, followed by 10 minutes of cool down.

Locations

Country Name City State
United States University of Southern California Department of Neurosurgery Los Angeles California

Sponsors (1)

Lead Sponsor Collaborator
University of Southern California

Country where clinical trial is conducted

United States, 

References & Publications (1)

Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: A summary report and call to action. Ann Neurol. 2017 Apr;81(4):479-484. doi: 10.1002/ana.24897. No abstract available. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence to exercise and assessments Number of completed exercise and assessment sessions Through study completion, an average of 6 months
Secondary Neurogenesis Number of new neurons per mm3 in surgically resected tissue after cell culture 13 weeks after first exercise session
Secondary Rey Auditory Verbal Learning Test (RAVLT) - Trial V The Rey Auditory Verbal Learning Test (RAVLT) is a validated test evaluating verbal learning and memory. In this test, lists of words are read to the participants in consecutive trials. Trial V is the 5th attempt at recalling the first list of words. Baseline and 12 weeks after first exercise session
Secondary Rey Auditory Verbal Learning Test (RAVLT) - Summary score The Rey Auditory Verbal Learning Test (RAVLT) is a validated test evaluating verbal learning and memory. In this test, lists of words are read to the participants in consecutive trials. Summary score is the sum of number of words learned over five learning trials. Baseline and 12 weeks after first exercise session
Secondary WAIS-IV - Matrix Reasoning Wechsler Adult Intelligence Scale Fourth Edition (WAIS-IV) is a validated test of cognitive ability and intelligence. Matrix reasoning is among the tasks included in WAIS-IV which is used to assess non-verbal abstract problem solving and inductive reasoning. Baseline and 12 weeks after first exercise session
Secondary Rey Complex Figure Test (RCFT) Rey Complex Figure Test (RCFT) is a standardized test of visuospatial memory. Performance will be scored based on the delayed recall trial of the RCFT. Baseline and 12 weeks after first exercise session
See also
  Status Clinical Trial Phase
Completed NCT06269822 - Autonomic Dysfunction in Temporal Lobe Epilepsy and SUDEP
Completed NCT05159609 - Closed Loop Auditory Stimulus in Sleep and epilepsY N/A
Completed NCT02946151 - Subcutaneous EEG in Epilepsy N/A
Not yet recruiting NCT02590419 - Application of Diffusion Tensor Imaging and Tractography in Epilepsy Surgery N/A
Completed NCT00595699 - Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy Phase 4
Recruiting NCT06466681 - Changes in Attentional Control After a Focal Seizure.
Recruiting NCT05609084 - Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy N/A
Completed NCT00344877 - Electrical Brain Stimulation to Reduce Epileptic Seizures N/A
Not yet recruiting NCT05794295 - Sleep Architecture & Intrinsic Oscillatory and Network Connectivity in Cognition and Executive Dysfunction in TLE N/A
Recruiting NCT03643471 - Advanced Magnetic Resonance Imaging in Temporal Lobe Epilepsy
Terminated NCT00717431 - A Multicenter Study of Hippocampal Electrical Stimulation (HS, in Mesial Temporal Lobe Epilepsy Phase 3
Completed NCT02844465 - Stereotactic Laser Ablation for Temporal Lobe Epilepsy N/A
Recruiting NCT05019404 - Minimally Invasive Surgical Epilepsy Trial for Temporal Lobe Epilepsy N/A